Naloxone Market Revenue Opportunities To 2026 Estimated by Global Top Players Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar, Inc., INSYS Therapeutics, Inc., Kaleo, Inc., INSYS Therapeutics, Inc., and Kern Pharma, S.L.

Naloxone is a medication which is mainly used to reverse opioid overdoses such as morphine and heroin. Naloxone is an opioid antagonist and the U.S. Food and Drug Administration (FDA) list it under prescription drugs, however, some countries such as Italy and Australia have rescheduled it as an over-the-counter (OTC) medication. Naloxone products are available in various strengths. Currently, the available strengths of naloxone include 0.4 mg/ml, 1mg/ml, 0.4mg/0.4ml, 4mg/0.1ml, and others. Naloxone is administrated from different routes such as intranasal, intramuscular/subcutaneous, and intravenous. Intranasal naloxone products are the latest product in the market which can be administrated by anyone (non-medical professional). However, intravenous products are mainly administrated by the medical professional who is properly trained.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1804

Market Dynamics:

Increasing launches and approval of new naloxone products in the market is expected to drive the global naloxone market growth over the forecast period. In October 2016 Health Canada approved Narcan Nasal Spray 4 mg for non-prescription, community use in Canada

Rising prevalence of opioid overdose in key regions such as North America and Europe is expected to drive demand for naloxone products and drive the naloxone market growth in the near future. For instance, according to the data published by European Monitoring Center for Drugs and Drug Addiction (EMCDDA), in 2016, around 150,943 high-risk opioid users were reported in Germany and around 330,445 were reported in the U.K.

Initiatives by various government and private organizations to increase access of naloxone product among the population is also expected to drive market growth. For instance, in 2015, Kaleo, Inc. partnered with the Clinton Foundation and provided bulk discounts on its EVZIO to various college universities and public safety organizations.

Key features of the study:

- This report provides in-depth analysis of naloxone market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017, as the base year

- It elucidates potential revenue opportunity across different segments and explains the attractive investment proposition matrix for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

- It profiles leading players in the global naloxone market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans

- Key companies covered as a part of this study include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.

- Insights from this report would allow marketers and the management authorities of the companies to make the informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

- The global naloxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the naloxone market

Naloxone Market Key Players:

Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.

Request For Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1804

Detailed Segmentation:

Global Naloxone Market, By Strength:
- 0.4 mg/ml
- 1mg/ml
- 0.4mg/0.4ml
- 4mg/0.1ml and Others

Global Naloxone Market, By Drug Type:
- Intranasal
- Intramuscular/Subcutaneous
- Intravenous

Global Naloxone Market, By Distribution Channel:
- Hospitals
- Clinics
- Retail Pharmacies
- Online Pharmacies
- Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.